These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 8895539)

  • 1. Chromosomal findings and p53-mutation analysis in chromophilic renal-cell carcinomas.
    Dijkhuizen T; Van den Berg E; Van den Berg A; Störkel S; De Jong B; Seitz G; Henn W
    Int J Cancer; 1996 Sep; 68(1):47-50. PubMed ID: 8895539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathologic and interphase cytogenetic analysis of papillary (chromophilic) renal cell carcinoma.
    Kattar MM; Grignon DJ; Wallis T; Haas GP; Sakr WA; Pontes JE; Visscher DW
    Mod Pathol; 1997 Nov; 10(11):1143-50. PubMed ID: 9388066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromosome 9 and 17 aberrations and p53 gene deletion detected by fluorescence in situ hybridization in renal-cell carcinoma.
    Yoshioka K; Nakamura S
    Mol Urol; 2001; 5(1):11-7. PubMed ID: 11689146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histopathological, cytogenetic, and molecular characterization of renal cortical tumors.
    Presti JC; Rao PH; Chen Q; Reuter VE; Li FP; Fair WR; Jhanwar SC
    Cancer Res; 1991 Mar; 51(5):1544-52. PubMed ID: 1671759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular genetic evidence for the independent origin of multifocal papillary tumors in patients with papillary renal cell carcinomas.
    Jones TD; Eble JN; Wang M; MacLennan GT; Delahunt B; Brunelli M; Martignoni G; Lopez-Beltran A; Bonsib SM; Ulbright TM; Zhang S; Nigro K; Cheng L
    Clin Cancer Res; 2005 Oct; 11(20):7226-33. PubMed ID: 16243792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal tubulocystic carcinoma is closely related to papillary renal cell carcinoma: implications for pathologic classification.
    Zhou M; Yang XJ; Lopez JI; Shah RB; Hes O; Shen SS; Li R; Yang Y; Lin F; Elson P; Sercia L; Magi-Galluzzi C; Tubbs R
    Am J Surg Pathol; 2009 Dec; 33(12):1840-9. PubMed ID: 19898225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutation of the p53 tumour suppressor gene occurs preferentially in the chromophobe type of renal cell tumour.
    Contractor H; Zariwala M; Bugert P; Zeisler J; Kovacs G
    J Pathol; 1997 Feb; 181(2):136-9. PubMed ID: 9120715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Numerical aberrations of chromosomes 1 and 7 in renal cell carcinomas as detected by interphase cytogenetics.
    Beck JL; Hopman AH; Feitz WF; Schalken J; Schaafsma HE; Van de Kaa CA; Ramaekers FC; Hanselaar AG; De Wilde PC
    J Pathol; 1995 Jun; 176(2):123-35. PubMed ID: 7636622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytogenetic analysis of epithelial renal-cell tumors: relationship with a new histopathological classification.
    van den Berg E; van der Hout AH; Oosterhuis JW; Störkel S; Dijkhuizen T; Dam A; Zweers HM; Mensink HJ; Buys CH; de Jong B
    Int J Cancer; 1993 Sep; 55(2):223-7. PubMed ID: 8370620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromosome 17p deletions and p53 mutations in renal cell carcinoma.
    Reiter RE; Anglard P; Liu S; Gnarra JR; Linehan WM
    Cancer Res; 1993 Jul; 53(13):3092-7. PubMed ID: 8319216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytogenetic profile predicts prognosis of patients with clear cell renal cell carcinoma.
    Klatte T; Rao PN; de Martino M; LaRochelle J; Shuch B; Zomorodian N; Said J; Kabbinavar FF; Belldegrun AS; Pantuck AJ
    J Clin Oncol; 2009 Feb; 27(5):746-53. PubMed ID: 19124809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infrequent involvement of p53 mutations and loss of heterozygosity of 17p in the tumorigenesis of renal cell carcinoma.
    Uchida T; Wada C; Shitara T; Egawa S; Mashimo S; Koshiba K
    J Urol; 1993 Oct; 150(4):1298-301. PubMed ID: 8103806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic organization and chromosomal localization of the human CUL2 gene and the role of von Hippel-Lindau tumor suppressor-binding protein (CUL2 and VBP1) mutation and loss in renal-cell carcinoma development.
    Clifford SC; Walsh S; Hewson K; Green EK; Brinke A; Green PM; Gianelli F; Eng C; Maher ER
    Genes Chromosomes Cancer; 1999 Sep; 26(1):20-8. PubMed ID: 10441001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing genetic heterogeneity of renal cell tumors.
    Mirghomizadeh F; Kupka S; Blin N
    Anticancer Res; 1999; 19(2C):1467-70. PubMed ID: 10365125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of chromosomes in clear cell renal cell carcinoma and in corresponding renal parenchyma.
    Feil G; Leipoldt M; Nelde HJ; Wunderer A; Wechsel HW; Kaiser P; Bichler KH
    Anticancer Res; 1999; 19(2C):1477-82. PubMed ID: 10365127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytogenetic alterations in renal tumors: a study of 38 Southeast Asian patients.
    Lau LC; Tan PH; Chong TW; Foo KT; Yip S
    Cancer Genet Cytogenet; 2007 May; 175(1):1-7. PubMed ID: 17498551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal cell carcinoma of end-stage renal disease: an analysis of chromosome 3, 7, and 17 abnormalities by microsatellite amplification.
    Hughson MD; Bigler S; Dickman K; Kovacs G
    Mod Pathol; 1999 Mar; 12(3):301-9. PubMed ID: 10102616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The value of molecular genetic analysis in the diagnosis and prognosis of renal cell tumours.
    Kovacs G
    World J Urol; 1994; 12(2):64-8. PubMed ID: 8087142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differentiation of multifocal renal cell carcinoma by comparative genomic hybridization.
    Junker K; Hindermann W; Schubert J; Schlichter A
    Anticancer Res; 1999; 19(2C):1487-92. PubMed ID: 10365129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of quantitative chromosomal abnormalities in renal cell carcinomas by interphase four-color fluorescence in situ hybridization.
    Receveur AO; Couturier J; Molinié V; Vieillefond A; Desangles F; Guillaud-Bataille M; Danglot G; Coullin P; Bernheim A
    Cancer Genet Cytogenet; 2005 Apr; 158(2):110-8. PubMed ID: 15796957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.